Meeting
2016 Palliative and Supportive Care in Oncology Symposium
Supportive Oncology Collaborative: Initial impact of supportive oncology screening and care.
Authors
Shelly S. Lo
Loyola University, Chicago, IL
Shelly S. Lo, Lauren Allison Wiebe, Catherine Deamant, Amy Scheu, Betty Roggenkamp, Urjeet Patel, Pam Khosla, Patricia A. Robinson, Frank J. Penedo, James Gerhart, William Dale, Oana Cristina Danciu, Rosa Berardi, Christine B. Weldon, Julia Rachel Trosman
Organizations
Loyola University, Chicago, IL, Rush University Medical Center, Chicago, IL, JourneyCare, Barrington, IL, Advocate Health Care, Oak Brook, IL, Center for Business Models in Healthcare, Chicago, IL, The John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, The Mount Sinai Comprehensive Cancer Center, Chicago, IL, Loyola University Medical Center, Maywood, IL, Northwestern University, Chicago, IL, University of Chicago Medicine, Chicago, IL, University of Illinois at Chicago, Chicago, IL, The Coleman Foundation, Chicago, IL, Northwestern University Feinberg School of Medicine, Chicago, IL
Research Funding
Other Foundation
Background: The Institute of Medicine (IOM) 2013 report recommends supportive oncology care from diagnosis through survivorship, to end of life. The Coleman Supportive Oncology Collaborative (CSOC) developed a city-wide plan to improve supportive oncology. Metrics derived from the Commission on Cancer (CoC), ASCO Quality Oncology Practice Initiative (ASCO-QOPI) and National Quality Forum (NQF) were used to assess the CSOC impact. Methods: Medical records of consecutive cancer patients from 6 practice improvement cancer centers in Chicago (3 academic, 2 safety-net, 1 public) were reviewed for 2 periods: 2014 (n = 843) and Q1 of 2015 (n = 313). Descriptive statistics assessed differences in quality metrics. Results: Significant improvement was achieved in 6 of 8 core supportive oncology metrics (see table). Conclusions: Consolidated metrics are feasible to assess supportive oncology quality. Early data indicate improvement and effectiveness of the collaborative approach.
| Metric (Reference) | % Patients dx in 2014 | % Patients dx in Q1 2015 | P value |
|---|---|---|---|
| *Documented discussion on understanding of illness, treatment expectation, or quality of life within 30 days (d) of diagnosis (dx) (QOPI 2 NQF 0386) | 54 (453/843) | 67 (210/313) | < 0.0001 |
| Patients provided prognosis timeframe (ds to weeks, weeks to months, months to years, years+) within 30 d of dx (QOPI 2 NQF 0386) | 24 (205/843) | 23 (71/313) | Not significant |
| *Documented health care agent / validated POA within 90 d of dx (QOPI 25a) | 5 (42/843) | 18 (58/313) | < 0.0001 |
| *Stage IV patients with documented advance directive / POLST discussion within 90 d of dx (QOPI 25a) | 1 (10/452) | 10 (10/103) | < 0.0001 |
| Stage I, II, III patients with supportive oncology needs screening within 30 d of dx (QOPI 24, CoC 3.2) | 38 (148/391) | 34 (72/210) | Not significant |
| Stage IV patients with supportive oncology needs screening within 14 d of dx (QOPI 24, CoC 3.2) | 6 (27/452) | 10 (10/103) | < 0.0001 |
| **Stage IV patients with documented palliative care referral (QOPI 43 NQF 0215) | 15 (68/452) | 30 (31/103) | = 0.0006 |
| *Stage I, II, III patients who received treatment summary and Survivor Care Plan within 180 d of treatment (QOPI 18, 20, CoC 3.3) | 2 (9/391) | 19 (33/172) | < 0.0001 |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Evaluation and Assessment of Patient Symptoms and Quality of Life,Integration and Delivery of Palliative Care in Cancer Care
Sub Track
Quality improvement activities
Citation
J Clin Oncol 34, 2016 (suppl 26S; abstr 180)
DOI
10.1200/jco.2016.34.26_suppl.180
Abstract #
180
Poster Bd #
K6
Abstract Disclosures
Similar Abstracts
Abstract
2016 ASCO Annual Meeting
Supportive oncology collaborative: Initial impact on supportive oncology screening and care across cancer centers.
First Author: Julia Rachel Trosman
Abstract
2023 ASCO Annual Meeting
Yoga vs. behavioral placebo for fatigue and quality of life among older cancer survivors.
First Author: Evelyn Arana
Abstract
2017 ASCO Quality Care Symposium
Supportive oncology and survivorship care: Initial impact of the Coleman Supportive Oncology Collaborative.
First Author: Julia Rachel Trosman
Abstract
2024 ASCO Annual Meeting
Randomized trial of a multimodal intervention to enhance sexual function and quality of life (QOL) in hematopoietic stem cell transplant (HSCT) survivors.
First Author: Areej El-Jawahri